Bruno Verhasselt
Overview
Explore the profile of Bruno Verhasselt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1830
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Janevska M, Witkowski W, Vermeire J, Borowicz M, Naessens E, Vanderstraeten H, et al.
J Virol
. 2025 Mar;
:e0206624.
PMID: 40029073
HIV-1 infects several types of CD4+ cells. Among these, dendritic cells (DCs) are considered one of the first to encounter the virus upon sexual transmission. Expression of several restriction factors,...
2.
De Jaeghere E, Hamerlinck H, Tuyaerts S, Lippens L, Van Nuffel A, Baiden-Amissah R, et al.
Gynecol Oncol
. 2024 Nov;
191():275-286.
PMID: 39515198
Background: The phase II PRIMMO trial investigated a pembrolizumab-based regimen in patients with recurrent and/or metastatic cervical (CC) or endometrial (EC) carcinoma who had at least one prior line of...
3.
Strubbe G, Van Honacker E, Vandendriessche S, Messiaen A, Verhasselt B, Boelens J
Acta Clin Belg
. 2024 Oct;
79(5):319-326.
PMID: 39450885
Introduction: To speed up antimicrobial susceptibility testing (AST), the European Committee on Antimicrobial Susceptibility Testing (EUCAST) proposed rapid AST (RAST), a disk diffusion method to be read after 4, 6...
4.
Holtz A, Van Weyenbergh J, Hong S, Cuypers L, OToole A, Dudas G, et al.
BMC Infect Dis
. 2024 Oct;
24(1):1139.
PMID: 39390446
We investigate the emergence, mutation profile, and dissemination of SARS-CoV-2 lineage B.1.214.2, first identified in Belgium in January 2021. This variant, featuring a 3-amino acid insertion in the spike protein...
5.
Janevska M, Cammaert T, Naessens E, Verhasselt B
J Virol
. 2024 Sep;
98(10):e0087724.
PMID: 39269176
Human immunodeficiency virus (HIV) type 2 is known to be less pathogenic than HIV-1, possibly due to more effective immune control mechanisms. The mechanism of innate sensing of HIV-2 by...
6.
Willems E, Hamerlinck H, Messiaen A, Schelstraete P, Van Braeckel E, Vande Weygaerde Y, et al.
Acta Clin Belg
. 2024 Aug;
:1-7.
PMID: 39101268
Objectives: This study aimed to evaluate an expanded matrix-assisted laser desorption-ionization-time of flight mass spectrometry (MALDI-TOF MS) database for the identification of species other than (Hi). Methods: A total of...
7.
Grassi L, Asfahl K, Van den Bossche S, Maenhout I, Sass A, Vande Weygaerde Y, et al.
Biofilm
. 2024 Jul;
7:100206.
PMID: 38975276
It is increasingly recognized that interspecies interactions may modulate the pathogenicity of during chronic lung infections. Nevertheless, while the interaction between and pathogenic microorganisms co-infecting the lungs has been widely...
8.
Bruggeman A, Vandendriessche C, Hamerlinck H, De Looze D, Tate D, Vuylsteke M, et al.
EClinicalMedicine
. 2024 Apr;
71:102563.
PMID: 38686220
Background: Dysregulation of the gut microbiome has been implicated in Parkinson's disease (PD). This study aimed to evaluate the clinical effects and safety of a single faecal microbiota transplantation (FMT)...
9.
Janssen R, Cuypers L, Laenen L, Keyaerts E, Beuselinck K, Janssenswillen S, et al.
Virol J
. 2024 Feb;
21(1):40.
PMID: 38341597
Since the onset of the coronavirus disease (COVID-19) pandemic in Belgium, UZ/KU Leuven has played a crucial role as the National Reference Centre (NRC) for respiratory pathogens, to be the...
10.
Van den Bossche S, Abatih E, Grassi L, De Broe E, Rigole P, Boelens J, et al.
Microbiol Spectr
. 2023 Nov;
11(6):e0044923.
PMID: 37982625
People with cystic fibrosis (pwCF) often suffer from chronic lung infections with . While antibiotics are still commonly used to treat infections, there is a high discordance between and antibiotic...